Navigation Links
Vista Partners Updates Coverage on Cellmid Limited; Raises Target Price to AUD $0.12
Date:11/16/2011

SAN FRANCISCO, Nov. 16, 2011 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Cellmid Ltd. (ASX: CDY) (the "Company") and raised its twelve month target price to AUD $0.12. Ross Silver, Principal Analyst at Vista Partners stated, "Cellmid is on track to enter clinical trials for its AMI indication with a market estimated to be in the billions. The Company recently completed humanisation of its "first in class" anti-midkine antibody, hu91, in collaboration with Antitope Ltd. The humanisation has been completed on time and within budget and resulted in a drug that can enter clinical development. This is the most significant milestone to date in the Company's antibody program and has removed a substantial risk from the clinical development path." Mr. Silver continued, "Cellmid has a large portfolio of patents surrounding midkine and owns 21 patent families worldwide. Cellmid plans to monetize this portfolio through two segments: Diagnostics and Therapeutics. The Diagnostic programs are in a more advanced stage and are poised to face regulatory approvals first. The Therapeutic programs are in pre-clinical trials; however they involve high value antibody candidates with early partner/licensing potential."

To download a FREE copy of the Cellmid Ltd. research report, please visit www.vistapglobal.com and complete the research form to gain access to the report.  

About Vista Partners:

Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners LLC has built a name for itself in the small cap space due to its selection of
'/>"/>

SOURCE Vista Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
3. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
4. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
5. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
6. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
7. NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO
8. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
9. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
10. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
11. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ADELAIDE, Australia , Aug. 31, 2015 ... the discovery and development of innovative therapeutics for the ... and cancer, today announced that its BNC101 IND submission ... Administration (FDA). Bionomics plans to initiate a Phase 1 ... in patients with metastatic pancreatic cancer prior to 31 ...
(Date:8/30/2015)... 30, 2015 La solución ... l cuidado al paciente a ... Royal Philips  (NYSE: PHG, AEX: ... IntelliSpace Cardiovascular , un sistema web de gestión de ... analizar y compartir imágenes cardiovasculares e información en cualquier ...
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
Breaking Medicine Technology:Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3CytomX Files Registration Statement for Proposed Initial Public Offering 2
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now ... Dr. Pedram Ghasri is a graduate of the University of California, Los Angeles. He ... studies at the University of California, Irvine Medical School. As a nationally recognized Regents ...
(Date:8/31/2015)... , ... August 31, 2015 , ... In preparation for ... Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 Reasons to ... as a way of coping with a variety of home healthcare challenges, specifically as ...
(Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since ... acknowledged September 26th as Mesothelioma Awareness Day . On this day, and in ... several ways of becoming involved and helping the cause. , “One of the ways ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a ... mobile walking app, Walkadoo , by including an in-app step tracker. , ... to each person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps ...
(Date:8/31/2015)... ... 2015 , ... It’s a lot like coming home. Life-long Fox Valley resident ... his first days on the job, he’s run into residents of the retirement community ... knowing that they’re living in such a wonderful place,” he said. GreenFields, which is ...
Breaking Medicine News(10 mins):Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2
... Benefits and Flavor of Fruit in a Zero-Calorie Fortified Water ... of Fruit2O(R), the original fruit flavored water, comes a new ... nutrients found in two servings of fruit with zero calories ... shown that 80 percent of Americans do not drink the ...
... ... Adoption of Healthcare Information Technology , ... Stamford, CT (PRWEB) June 4, 2009 -- IVANS, Inc. , ... survey that showed healthcare providers believe in the importance of reform, but are concerned ...
... Continued Market Leadership in Parenteral and Solutions/Nutritionals , ... Inc. (B. Braun) today announced that it had received ... highest year-over-year market share growth for distributed products in the ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ...
... overburdened if an outbreak were more severe , THURSDAY, June ... H1N1 swine flu outbreak that surfaced unexpectedly in April has ... , And those shortcomings could take on added urgency if ... fall, a new report found. , "It,s clear that ...
... , , HARRISBURG, Pa., June 4 Pennsylvania ... Estoydecidido.com , a resource tool to help Latino residents ... -- which translates to "I am determined" -- is ... site. , , "Latinos have become an emerging ...
... and the Alzheimer Research Forum announce the release of the ALS ... ), a web-based resource for researchers interested in amyotrophic lateral sclerosis ... The site is modeled on the Alzheimer Research Forum,s popular ... efforts to build a similar set of tools for ALS researchers. ...
Cached Medicine News:Health News:Fruit2O(R) Introduces New 'Essentials' Line 2Health News:Fruit2O(R) Introduces New 'Essentials' Line 3Health News:Providers Believe Healthcare Reform Will Increase Their Costs, According to IVANS Survey 2Health News:Providers Believe Healthcare Reform Will Increase Their Costs, According to IVANS Survey 3Health News:B. Braun Medical Wins Two GHX 2009 Best in Class Awards 2Health News:B. Braun Medical Wins Two GHX 2009 Best in Class Awards 3Health News:Report Gives U.S. Good Grades for Swine Flu Response 2Health News:Report Gives U.S. Good Grades for Swine Flu Response 3Health News:Report Gives U.S. Good Grades for Swine Flu Response 4Health News:Pennsylvania Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research 2Health News:Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research 3
... The Mini-PROTEAN 3 Dodeca cell runs ... conditions in just 35 minutes. Handcast gels ... with the new Model 485 gradient former ... of variation and improving reproducibility. Alternatively, Ready ...
... E-Gel® 96 and E-Gel® 48 gels ... bases, which combine the base and power ... device connects to the mother E-Base™ and ... simultaneous electrophoresis of two or more E-Gel® ...
... E-Page™ High-Throughput (HTP) Protein ... only integrated pre-cast gel ... high-throughput protein analysis. It ... gels, E-Base™ integrated power ...
... design allows "Four gels in one tank" electrophoresis. ... run 200 samples or more in one compact ... gels. To ensure even migration, the electrode height ... being run. Ideal for high throughput procedures, an ...
Medicine Products: